SRI International
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1946-11-06
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.sri.com
Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System
Terminated
- Conditions
- Anthrax
- Interventions
- Diagnostic Test: Anthrax LF Dx System
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- SRI International
- Target Recruit Count
- 343
- Registration Number
- NCT05672875
- Locations
- 🇺🇸
WellNow Urgent Care and Research, Dayton, Ohio, United States
Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- SRI International
- Target Recruit Count
- 42
- Registration Number
- NCT05628961
- Locations
- 🇺🇸
SRI Biosciences Clinical Trials Unit, Plymouth, Michigan, United States
Sleep and Emotional Reactivity in Alcohol Use Disorder
Not Applicable
- Conditions
- Alcohol Use Disorder (AUD)
- Interventions
- Other: Uninterrupted sleep followed by functional neuroimaging.
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- SRI International
- Target Recruit Count
- 100
- Registration Number
- NCT04979507
- Locations
- 🇺🇸
SRI International, Menlo Park, California, United States
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine
Phase 1
- Conditions
- EncephalomyelitisBrain DiseasesCentral Nervous System DiseasesCentral Nervous System InfectionsCentral Nervous System Viral DiseasesTogaviridae InfectionsEncephalitisEncephalitis, ViralInfectious EncephalitisVirus Diseases
- Interventions
- Biological: Vaccinations on Day 0, Day 28, and Day 140
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- SRI International
- Target Recruit Count
- 48
- Registration Number
- NCT03776994
- Locations
- 🇺🇸
SRI Biosciences Clinical Trials Unit, Plymouth, Michigan, United States
Sleep and Cardiovascular Health in Adolescence
Not Applicable
Completed
- Conditions
- Insomnia Type; Sleep Disorder
- Interventions
- Other: No pre-sleep arousal manipulationOther: pre-sleep arousal down-regulationOther: pre-sleep arousal up-regulation
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2023-05-01
- Lead Sponsor
- SRI International
- Target Recruit Count
- 115
- Registration Number
- NCT03727906
- Locations
- 🇺🇸
SRI International, Menlo Park, California, United States
Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging
Not Applicable
Withdrawn
- Conditions
- Skin Manifestations
- Interventions
- Drug: TDS Lidocaine 5%; genericDrug: TDS Lidocaine 5%; RLD
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- SRI International
- Registration Number
- NCT02787356
Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking
Not Applicable
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2006-03-10
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- SRI International
- Target Recruit Count
- 1200
- Registration Number
- NCT00301145
- Locations
- 🇺🇸
SRI International, Menlo Park, California, United States
🇺🇸Center for Health Studies, Seattle, Washington, United States
🇺🇸Free & Clear, Incorporated, Seattle, Washington, United States
Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- SRI International
- Target Recruit Count
- 146
- Registration Number
- NCT00166543
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath